Showing 821-830 of 1093 results for "".
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di
- BeautyHealth and LaserAway Expand Partnershiphttps://modernaesthetics.com/news/beautyhealth-and-laseraway-expand-partnership/2473464/The Beauty Health Company will supply Hydrafacial Syndeo devices to LaserAway’s locations across the U.S. and any new practice sites opened through 2025. Syndeo combines Hydrafacial’s patented vortex fusion technology with a digital experience. Using Syndeo’s con
- Allergan Aesthetics Announces First JUVÉDERM Dayhttps://modernaesthetics.com/news/allergan-aesthetics-announces-first-ever-juvederm-day/2473461/August 16, 2023 marks the first ever JUVÉDERM® Day. JUVÉDERM Day provides both con
- SK-II Introduces Pitera Expert Panelhttps://modernaesthetics.com/news/sk-ii-introduces-pitera-expert-panel/2473450/SK-II’s PITERA may reduce the Aging Trigger Factor (AT-0), potentially slowing skin aging, according to research presented at the World Congress of Dermatology 2023 in Singapore. AT-0 accelerates signs of aging via a chain reaction, even as early as i
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- Acclaro Medical Rolls Our Rebranded UltraClear Cold Fiber Laserhttps://modernaesthetics.com/news/acclaro-medical-rolls-our-rebranded-ultraclear-cold-fiber-laser/2473448/Meet the newly re-branded UltraClear Cold Fiber Laser from Acclaro Medical. From a design perspective, rebranding encompasses an updated logo and color palette and aims to increase recognition of UltraClear's 3DIntelliPulse technology and its ability to provide optima
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Eyebrow Thickness? It’s in Your Geneshttps://modernaesthetics.com/news/eyebrow-thickness-its-in-your-genes/2473425/The first gene mapping study on eyebrow thickness in Europeans discovered three previously unreported genetic loci, suggesting that eyebrow appearance has partly the same and partly different underlying genes in people from different parts of the world. The study, conducted by the Inter